Try For Free 7-Day Free Trial
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
|Overall||21 of 35|
|Sector (Life Science)||18 of 26|
|Type (IPO)||2 of 9|
|State (Massachusetts)||2 of 2|
|Country (United States)||21 of 35|
|Year (2013)||2 of 3|
Stamford, Connecticut, United States
Loxo Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. Loxo Oncology, Inc. was founded in 2013 and is based in Stamford, Connecticut.
Durham, North Carolina, United States
IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.